Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by Nuvan Rathnayaka
At Target RWE, we are dedicated to enhancing the reliability and reproducibility of real-world evidence (RWE). Our latest research from the DIA Real-World Evidence (RWE) 2024 conference delves into advanced strategies designed to sharpen inter-team communication and minimize potential errors in RWE studies. Nuvan Rathnayaka, Target RWE Manager of Biostatistics, provides insights into this innovative approach and discusses how effective communication frameworks can drive more accurate real-world data analysis.
Watch the video below to gain a first-hand look at the presented research titled 'Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence.'
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
Kayla Slake
Senior Manager, Marketing
984.234.0268 ext 205
More News
-
04/25/2025
How does causalStudio™ address the key regulatory requirements for data integrity, traceability, and analysis? -
04/03/2025
An Overview of MASH: Advancements in Diagnosis, Treatment, and the Role of Real-World Data -
03/31/2025
Addressing the Burden of Hidradenitis Suppurativa: The Often-Hidden Impact on Quality of Life -
03/18/2025
AASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry) -
03/07/2025
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology Studies